NUVA * Stock Overview
NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 3/6 |
| Past Performance | 2/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
NuVasive, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$1,079.09 |
| 52 Week High | US$1,147.67 |
| 52 Week Low | US$999.33 |
| Beta | 1.07 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 9.91% |
Recent News & Updates
Recent updates
Shareholder Returns
| NUVA * | MX Medical Equipment | MX Market | |
|---|---|---|---|
| 7D | 0% | 0% | 0% |
| 1Y | n/a | 0% | 0% |
Return vs Industry: Insufficient data to determine how NUVA * performed against the MX Medical Equipment industry.
Return vs Market: Insufficient data to determine how NUVA * performed against the MX Market.
Price Volatility
| NUVA * volatility | |
|---|---|
| NUVA * Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 0% |
| Market Average Movement | 0% |
| 10% most volatile stocks in MX Market | 0% |
| 10% least volatile stocks in MX Market | 0% |
Stable Share Price: NUVA * has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine NUVA *'s volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1997 | 3,000 | Chris Barry | www.nuvasive.com |
NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal implants to advance spinal fusion by enhancing the osseointegration and biomechanical properties of implant materials, including porous titanium and porous polyetheretherketone; and fixation system that facilitates the preservation and restoration of patient alignment. The company also offers cervical total disc replacement technology for cervical spinal fusion surgery; neuromonitoring systems, which use proprietary software-driven nerve detection and avoidance technology, and its intraoperative neuromonitoring services and support; and Pulse platform, a software ecosystem that integrates multiple hardware technologies into a single, condensed footprint in the operating room.
NuVasive, Inc. Fundamentals Summary
| NUVA * fundamental statistics | |
|---|---|
| Market cap | Mex$40.26b |
| Earnings (TTM) | Mex$729.17m |
| Revenue (TTM) | Mex$21.69b |
55.2x
P/E Ratio1.9x
P/S RatioIs NUVA * overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NUVA * income statement (TTM) | |
|---|---|
| Revenue | US$1.20b |
| Cost of Revenue | US$336.51m |
| Gross Profit | US$865.44m |
| Other Expenses | US$825.03m |
| Earnings | US$40.41m |
Last Reported Earnings
Dec 31, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.77 |
| Gross Margin | 72.00% |
| Net Profit Margin | 3.36% |
| Debt/Equity Ratio | 102.7% |
How did NUVA * perform over the long term?
See historical performance and comparison